Julie Rubinstein $ADPT SEC Form 4 Insider Trading

Julie Rubinstein has filed a total of 53 insider trades in $ADPT since 2021. Their most recent trade was a sale of 19,037 shares, made on Apr 27, 2026. Their largest trade was a sale of 122,523 shares, made on Mar 11, 2026. We estimate that they now own 401,192 shares of $ADPT, worth an estimated $5.5 million.

Insider Trading at $ADPT

There have been a total of 256 insider trades reported at $ADPT since 2021, with 0 shares purchased and 6.9 million shares sold. The most active insider traders in $ADPT stock have been Julie Rubinstein, Harlan S Robins, and Chad M Robins. The most recent trade was a sale of 19,037 shares reported by JULIE RUBINSTEIN (President and COO), made on Apr 27, 2026.

$ADPT Executives and Stock Owners with Insider Trades

• Julie Rubinstein, President and COO

• Harlan S Robins, Chief Scientific Officer

• Chad M Robins, CEO and Chairman

• R Mark Adams, Chief Operating Officer

• Chad M Cohen, Chief Financial Officer

• Francis Lo, Chief People Officer

• Stacy L Taylor, SVP and General Counsel

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Nitin Sood, Chief Commercial Officer, MRD

• Kyle Piskel, Principal Accounting Officer

• Tycho Peterson, Chief Financial Officer

• Susan Bobulsky, Chief Commercial Officer, MRD

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Lance Baldo, Chief Medical Officer

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.